![Matthew Hammond](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Hammond
Director/Board Member at
Realm Therapeutics, Inc.
Profile
Currently, Matthew Charles Perrins Hammond occupies the position of Managing Director & Chief Financial Officer at Mail.ru Group Ltd. Mr. Hammond is also on the board of Strike Resources Ltd. (Australia) and PuriCore, Inc. In the past he was Group Strategist at Metalloinvest Holding Co. JSC and Technology Analyst at Credit Suisse Securities (Europe) Ltd. Mr. Hammond received an undergraduate degree from the University of Bristol.
Matthew Hammond active positions
| Companies | Position | Start |
|---|---|---|
Realm Therapeutics, Inc.
 Realm Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of ESSA Pharma, Inc., Realm Therapeutics, Inc. is a company that specializes in precision brain stimulation therapies to address memory loss caused by brain injury and degenerative diseases such as Alzheimer's. The company is based in Radnor, PA. The company's technology, developed at the University of Pennsylvania with DARPA funding, aims to enhance memory, reduce disability, and boost productivity for patients. By utilizing artificial intelligence to analyze brain activity patterns, the company's device delivers personalized stimulation to improve memory performance. The company is currently in the preclinical testing phase and is preparing for FDA approval to conduct clinical trials for patients with memory loss from traumatic brain injury. | Director/Board Member | - |
Former positions of Matthew Hammond
| Companies | Position | End |
|---|---|---|
| STRIKE RESOURCES LIMITED | Director/Board Member | 2024-09-26 |
Quanergy Perception Technologies, Inc.
 Quanergy Perception Technologies, Inc. Aerospace & DefenseElectronic Technology Develops and manufactures light detection and sensors & dimensional sensing solutions | Director/Board Member | 2022-09-29 |
| VK COMPANY LIMITED | Chief Executive Officer | 2021-12-12 |
| REALM THERAPEUTICS PLC | Director/Board Member | 2017-11-16 |
| QIWI PLC | Director/Board Member | 2014-09-28 |
Training of Matthew Hammond
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
79
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Strike Resources Ltd. (Australia)
 Strike Resources Ltd. (Australia) SteelNon-Energy Minerals Engages in the exploration and evaluation of iron ore projects | Non-Energy Minerals |
Realm Therapeutics Plc
 Realm Therapeutics Plc Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops proprietary immunomodulatory products | Health Technology |
Quanergy Perception Technologies, Inc.
Quanergy Perception Technologies, Inc. Aerospace & DefenseElectronic Technology Develops and manufactures light detection and sensors & dimensional sensing solutions | Electronic Technology |
Credit Suisse Securities (Europe) Ltd.
 Credit Suisse Securities (Europe) Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
University of Bristol
 University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nautilus Minerals, Inc.
 Nautilus Minerals, Inc. Precious MetalsNon-Energy Minerals Engages in the exploration of ocean floor for copper, gold, silver and zinc deposits activities | Non-Energy Minerals |
QIWI Plc
 QIWI Plc Miscellaneous Commercial ServicesCommercial Services Provides payment processing services | Commercial Services |
VK International PJSC
 VK International PJSC Internet Software/ServicesTechnology Services Operates communication and social platforms | Technology Services |
Realm Therapeutics, Inc.
Realm Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of ESSA Pharma, Inc., Realm Therapeutics, Inc. is a company that specializes in precision brain stimulation therapies to address memory loss caused by brain injury and degenerative diseases such as Alzheimer's. The company is based in Radnor, PA. The company's technology, developed at the University of Pennsylvania with DARPA funding, aims to enhance memory, reduce disability, and boost productivity for patients. By utilizing artificial intelligence to analyze brain activity patterns, the company's device delivers personalized stimulation to improve memory performance. The company is currently in the preclinical testing phase and is preparing for FDA approval to conduct clinical trials for patients with memory loss from traumatic brain injury. | Commercial Services |
- Stock Market
- Insiders
- Matthew Hammond
